Medanta reported 25% YoY revenue growth to ₹11,958 million in Q4 FY26, with a 40% rise in PAT to ₹1,417 million.
The new 550-bed Noida hospital ramped up to 382 operational beds, reducing its EBITDA loss to ₹236 million in Q4 from ₹320 million in Q3.
The Board recommended a final dividend of ₹0.50 per share and approved a 400-bed greenfield project in Varanasi via a build-to-suit lease.
The company plans to add ~500 beds with minimal capex in the short term and ~2,700 beds via 5 greenfield projects over 3-4 years with a ₹45,000 million capex plan.